Your browser doesn't support javascript.
loading
Tamoxifen Metabolism and Efficacy in Breast Cancer: A Prospective Multicenter Trial.
Neven, Patrick; Jongen, Lynn; Lintermans, Anneleen; Van Asten, Kathleen; Blomme, Chantal; Lambrechts, Diether; Poppe, An; Wildiers, Hans; Dieudonné, Anne-Sophie; Brouckaert, Olivier; Decloedt, Jan; Berteloot, Patrick; Verhoeven, Didier; Joerger, Markus; Vuylsteke, Peter; Wynendaele, Wim; Casteels, Minne; Van Huffel, Sabine; Lybaert, Willem; Van Ginderachter, Johan; Paridaens, Robert; Vergote, Ignace; Dezentjé, Vincent Olaf; Van Calster, Ben; Guchelaar, Henk-Jan.
Afiliação
  • Neven P; Department of Oncology, KU Leuven-University of Leuven, Leuven, Belgium. patrick.neven@uzleuven.be.
  • Jongen L; Department of Gynaecology and Obstetrics, University Hospitals Leuven, Leuven, Belgium.
  • Lintermans A; Department of Oncology, KU Leuven-University of Leuven, Leuven, Belgium.
  • Van Asten K; Department of Oncology, KU Leuven-University of Leuven, Leuven, Belgium.
  • Blomme C; Department of Oncology, KU Leuven-University of Leuven, Leuven, Belgium.
  • Lambrechts D; Department of Gynaecology and Obstetrics, University Hospitals Leuven, Leuven, Belgium.
  • Poppe A; Department of Human Genetics, Laboratory for Translational Genetics, KU Leuven-University of Leuven, Leuven, Belgium; VIB Vesalius Research Centre, Laboratory for Translational Genetics, Leuven, Belgium.
  • Wildiers H; Department of Gynaecology and Obstetrics, University Hospitals Leuven, Leuven, Belgium.
  • Dieudonné AS; Department of Oncology, KU Leuven-University of Leuven, Leuven, Belgium.
  • Brouckaert O; Department of Medical Oncology, University Hospitals Leuven, Leuven, Belgium.
  • Decloedt J; Department of Oncology, KU Leuven-University of Leuven, Leuven, Belgium.
  • Berteloot P; Department of Gynaecology and Obstetrics, University Hospitals Leuven, Leuven, Belgium.
  • Verhoeven D; Department of Gynaecology and Obstetrics, Algemeen Ziekenhuis Sint-Blasius, Dendermonde, Belgium.
  • Joerger M; Department of Gynaecology and Obstetrics, Algemeen Ziekenhuis Sint-Maarten, Duffel, Belgium.
  • Vuylsteke P; Department of Medical Oncology, Algemeen Ziekenhuis Klina, Brasschaat, Belgium.
  • Wynendaele W; Department of Medical Oncology and Hematology, Cantonal Hospital, St. Gallen, Switzerland.
  • Casteels M; Department of Medical Oncology, Université catholique de Louvain, CHU UCL, Namur site Sainte-Elisabeth, Namur, Belgium.
  • Van Huffel S; Department of Medical Oncology, Imelda Ziekenhuis, Bonheiden, Belgium.
  • Lybaert W; Department of Clinical Pharmacology and Pharmacotherapy, KU Leuven-University of Leuven, Leuven, Belgium.
  • Van Ginderachter J; Department of Electrical Engineering, KU Leuven-University of Leuven, Leuven, Belgium.
  • Paridaens R; Imec, Leuven, Belgium.
  • Vergote I; Department of Medical Oncology, Algemeen Ziekenhuis Nikolaas, Sint-Niklaas, Belgium.
  • Dezentjé VO; Department of Gynaecology and Obstetrics, Algemeen Ziekenhuis Maria Middelares, Ghent, Belgium.
  • Van Calster B; Department of Oncology, KU Leuven-University of Leuven, Leuven, Belgium.
  • Guchelaar HJ; Department of Medical Oncology, University Hospitals Leuven, Leuven, Belgium.
Clin Cancer Res ; 24(10): 2312-2318, 2018 05 15.
Article em En | MEDLINE | ID: mdl-29459457

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Tamoxifeno / Neoplasias da Mama / Antineoplásicos Hormonais / Moduladores Seletivos de Receptor Estrogênico Tipo de estudo: Clinical_trials / Diagnostic_studies / Risk_factors_studies Limite: Aged / Aged80 / Female / Humans / Middle aged Idioma: En Ano de publicação: 2018 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Tamoxifeno / Neoplasias da Mama / Antineoplásicos Hormonais / Moduladores Seletivos de Receptor Estrogênico Tipo de estudo: Clinical_trials / Diagnostic_studies / Risk_factors_studies Limite: Aged / Aged80 / Female / Humans / Middle aged Idioma: En Ano de publicação: 2018 Tipo de documento: Article